Berkley Renewables Inc. Share Price

Equities

BKS

CA0844941033

Oil & Gas Exploration and Production

Market Closed - Canadian Securities Exchange 14:30:00 10/04/2019 BST 5-day change 1st Jan Change
0.04 CAD +14.29% Intraday chart for Berkley Renewables Inc. -.--% -.--%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site

Financials

Sales 2016 1.03M 752K 59.33M Sales 2017 1.72M 1.25M 98.96M Capitalization 729K 530K 41.82M
Net income 2016 - 0 0 Net income 2017 - 0 0 EV / Sales 2016 3.53 x
Net Debt 2016 2.92M 2.12M 167M Net Debt 2017 4.76M 3.46M 273M EV / Sales 2017 3.18 x
P/E ratio 2016
4.22 x
P/E ratio 2017
-1.16 x
Employees -
Yield 2016 *
-
Yield 2017
-
Free-Float 90.7%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 61 19/06/02
Director/Board Member 62 28/07/04
Members of the board TitleAgeSince
Director/Board Member 62 28/07/04
Chief Executive Officer 61 19/06/02
Director/Board Member 64 16/08/06
More insiders
Berkley Renewables Inc. is a Canada-based growth-oriented diversified issuer also pursuing renewable energy opportunities, primarily in the solar energy sector. The Company is pursuing solar energy investments in Ontario, Canada. It is also engaged in developing autologous cell therapies to treat conditions linked to a deficit of healthy cells required for normal healing and function through RepliCel Life Sciences Inc. (RepliCel). RepliCel's RCT-01, RCS-01, and RCH-01 cell therapies are designed to treat chronic tendinosis, damaged or aged skin and pattern baldness. RepliCel is also developing an injection device (RCI) for optimal clinical delivery. It is developing solar photovoltaic (PV) projects in Ontario, Canada, through its subsidiary, Solar Flow-Through General Partnership. Working with Solar Flow-Through, the Company has also developed a flow-through investment vehicle for investors to participate in Ontario's solar energy growth.
More about the company
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW